Toxoplasmosis Treatment Alternative Announced in Response to Price Increase
Imprimis Pharmaceuticals announced that it has made available a compounded formulation of pyrimethamine and leucovorin.
All articles by Elizabeth Gough-Gordon, Digital Content Editor
Updated Online Tool Designed to Assist Users Track Foodborne Outbreaks
The Centers for Disease Control and Prevention (CDC) has launched an updated Foodborne Outbreak Online Database Tool (FOOD Tool) to assist users in searching over nearly 20 years of outbreak data.
Study Calls for Research into Antivirals and Placental Drug Transport
Pregnant women taking antiviral medications to treat hepatitis C and/or HIV with non-steroidal anti-inflammatories (NSAIDs) or antihypertensives may have an increased risk of birth defects or stunted fetal growth, although these antiviral drugs have not been shown to directly cause harm to a fetus.
FDA Orders Additional Duodenoscope Cleaning Studies
The Food and Drug Administration (FDA) has ordered the three manufacturers of duodenoscopes marketed in the United States to conduct postmarket surveillance studies for greater understanding of how the devices are reprocessed in real-world settings.
ACP Releases Guidelines for Unexplained Chronic Cough
The American College of Chest Physicians has issued an evidence-based guideline on appropriate treatments for unexplained chronic cough (UCC), including pharmacotherapy and speech pathology.
Getting Set for ICD-10
The newly expanded codes in ICD-10 will grant healthcare professionals greater specificity and clinical accuracy for noting procedures and diagnoses, but could also present obstacles and headaches in the transition from the previous ICD-9 codes.
Price for Toxoplasmosis Pill Drops Following IDSA, HIVMA Letter
Turing Pharmaceuticals has agreed to reduce the cost of its drug Daraprim (pyrimethamine) after receiving significant criticism due to a sudden increase in the price of the medication.
Treating Influenza Quickly Lowers Need for Extended Care in Elderly
Prompt antiviral therapy can reduce the need for extended care among community-dwelling patients aged ≥65 in this first-of-its-kind research.
No New HIV Infections Reported With PrEP in Clinical Setting
One of the first and largest published studies of PrEP in a clinical setting found no new cases of HIV among patients after initiation of PrEP.
Patients With HIV May Require Additional MMR Vaccine
Even with vaccination, children with HIV may not have sufficient immunity against measles, mumps, and rubella.
